Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case

Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case

Ortega-Villa, A. M., Hynes, N. A., Levine, C. B., Yang, K., Wiley, Z., Jilg, N., Wang, J., Whitaker, J. A., Colombo, C. J., Nayak, S. U., Kim, H. J., Iovine, N. M., Ince, D., Cohen, S. H., Langer, A. J., Wortham, J. M., Atmar, R. L., El Sahly, H. M., Jain, M. K. & Mehta, A. K. & 22 others, Wolfe, C. R., Gomez, C. A., Beresnev, T., Mularski, R. A., Paules, C. I., Kalil, A. C., Branche, A. R., Luetkemeyer, A., Zingman, B. S., Voell, J., Whitaker, M., Harkins, M. S., DaveyJr, R. T., Grossberg, R., George, S. L., Tapson, V., Short, W. R., Ghazaryan, V., Benson, C. A., Dodd, L. E., Sweeney, D. A. & Tomashek, K. M., Jun 1 2023, In: Open Forum Infectious Diseases. 10, 6, ofad290.

Research output: Contribution to journal › Article › peer-review

 See All News